1 |
Hartman M, Czene K,Reilly M, et al (2007). Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol, 25, 4210-16.
DOI
|
2 |
Carmichael AR, Bendall S, Lockerbie L, et al (2002). The long-term outcome of synchronous bilateral breast cancer is worse than meta-chronous or unilateral tumours. Eur J Surg Oncol, 28, 388-91.
DOI
ScienceOn
|
3 |
Heron DE, Komarnicky LT, Hyslop T, et al (2000). Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer, 88, 2739-50.
DOI
|
4 |
Quan G, Pommier SJ, Pommier RF (2008) Incidence and outcomes of contralateral breast cancers. Am J Surg, 195, 645-50.
DOI
|
5 |
Kheirelseid E A H, Jumustafa H, Miller N, et al (2011). Bilateral breast cancer: analysis of incidence, of survival and disease characteristics. Breast Cancer Res Treat, 126, 131-40.
DOI
|
6 |
Tsyhyka DY, Hotko YS and Devinyak (2013). Receptor status of tumor as prognostic factor in patients with bilateral breast cancer. Exp Oncol, 35, 291-4.
|
7 |
Chen SF, Du CW, Yang P, et al (2013). The molecular and clinicopathologic characteristics of bilateral breast cancer. Scientific reports/3:2590/DOI, 10, 1038.
DOI
|
8 |
Vuoto HD, Garcia AM, Candas GB, et al (2010). Bilateral breast carcinoma: clinical characteristics and its impact on survival. Breast J, 6, 625-32.
|
9 |
Roder D, et al (2013). Survival from synchronous bilateral breast cancer: The experience of surgeons participating in the breast audit of the society of breast surgeons of Australia and New Zealand. Asian Pacific J Cancer Prev, 13, 4571-5.
|
10 |
Baykara M, Ozturk SC, Buyukberber S, et al (2012). Clinicopathological features in bilateral breast cancer. Asian Pacific J Cancer Prev, 13, 4571-5.
DOI
|
11 |
Liang X, Li D, Geng W, Cao X, et al (2013). The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients. Tumor biology, 2, 995-1004.
|